Luce Lépissier
9Patents
1h-index
27Co-inventors
43Inventor score
Filing activity: Jun 3, 2016 → Aug 2, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10710994B2 | Oxadiazole transient receptor potential channel inhibitors | Chemistry; Metallurgy | 1 | Active |
| US11124527B2 | Compounds for the modulation of Myc activity | Human Necessities | 1 | Active |
| US11753418B2 | Compounds for the modulation of Myc activity | Chemistry; Metallurgy | 0 | Active |
| US10787444B2 | Compounds for the modulation of myc activity | Chemistry; Metallurgy | 0 | Active |
| US12202824B2 | Oxadiazole transient receptor potential channel inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10711004B2 | Oxadiazole transient receptor potential channel inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10654861B2 | Fused pentacyclic imidazole derivatives as modulators of TNF activity | Chemistry; Metallurgy | 0 | Active |
| US11655245B2 | Oxadiazole transient receptor potential channel inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11274103B2 | Compounds for the modulation of MYC activity | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.